Camp4 Therapeutics (CAMP) Capital Leases (2023 - 2025)

Camp4 Therapeutics (CAMP) has 3 years of Capital Leases data on file, last reported at $47000.0 in Q3 2025.

• For the quarter ending Q3 2025, Capital Leases fell 45.98% year-over-year to $47000.0; the trailing twelve-month figure through Sep 2025 stood at $47000.0 (down 45.98% YoY), and the FY2024 full-year result was $70000.0, down 52.7% from the prior year.
• Capital Leases slipped to $47000.0 in Q3 2025, from $59000.0 in the prior quarter.
• In the past five years, Capital Leases ranged from a high of $148000.0 in Q4 2023 to a low of $47000.0 in Q3 2025.
• A 3-year average of $78166.7 and a median of $64500.0 in 2024 frame the typical range for Capital Leases.
• Across the five-year window, Capital Leases tumbled 52.7% in 2024 and sank 45.98% in 2025, its largest moves.
• Tracing CAMP's Capital Leases over 3 years: stood at $148000.0 in 2023, then plunged by 52.7% to $70000.0 in 2024, then sank by 32.86% to $47000.0 in 2025.
• Business Quant data shows CAMP's Capital Leases at $47000.0 in Q3 2025, $59000.0 in Q2 2025, and $58000.0 in Q1 2025.